Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00782730 · ClinicalTrials.gov registry record

Assessment of Third Trimester Post-void Residual and Validation of Bladder Scanner in Pregnancy and Post-partum

A clinical trial of Pregnancy, sponsored by West Virginia University.

Completed
Registry status
35
Enrollment target
1
Study location

NCT00782730: Completed study of Pregnancy, sponsored by West Virginia University.

NCT00782730 is a study of Pregnancy that has completed, run by West Virginia University. The registered enrollment target is 35 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00782730, a study of Pregnancy, has completed, sponsored by West Virginia University.

COMPLETED
Registry status
35 participants
Enrollment target
1
Study location

Study Summary

This will be a descriptive study measuring the post-void residual of patients in the third trimester and postpartum. Also, bladder scan values will be compared to the amount of urine obtained from a Foley catheter to determine the accuracy of the bladder scanner in the third trimester and postpartum.

Conditions Studied

Study Locations (1)

West Virginia

  • West Virginia University - Morgantown

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2008-10
West Virginia University

122 total trials

What the finished NCT00782730 record still lists

NCT00782730 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 0 interventions.

NCT00782730 reports a single indexed study location in West Virginia.

Frequently Asked Questions

What is clinical trial NCT00782730 about?

NCT00782730 is a clinical study titled "Assessment of Third Trimester Post-void Residual and Validation of Bladder Scanner in Pregnancy and Post-partum". This will be a descriptive study measuring the post-void residual of patients in the third trimester and postpartum. Also, bladder scan values will be compared to the amount of urine obtained from a Foley catheter to determine the accuracy of the bladder scanner in the third trimester and postpartum...

What is the current status of trial NCT00782730?

This trial is currently completed. The enrollment target is 35 participants. The study started on 2008-10.

What conditions does trial NCT00782730 study?

This clinical trial studies the following conditions: Pregnancy.

Who is sponsoring clinical trial NCT00782730?

This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00782730 being conducted?

This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00782730's enrollment target sits among peer trials

35 169th of 191 higher than 23 of 191 other Pregnancy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00782730, the US trial registry maintained by the National Library of Medicine. NCT00782730 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.